Tower Research Capital (TRC)’s Biote Corp BTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18K Buy
13,361
+9,349
+233% +$18.8K ﹤0.01% 3549
2025
Q4
$10.4K Sell
4,012
-1,631
-29% -$4.46K ﹤0.01% 3776
2025
Q3
$16.9K Sell
5,643
-1,291
-19% -$4.61K ﹤0.01% 3456
2025
Q2
$27.9K Sell
6,934
-10,348
-60% -$38.2K ﹤0.01% 3461
2025
Q1
$57.5K Buy
17,282
+15,872
+1,126% +$75.7K ﹤0.01% 2132
2024
Q4
$8.71K Sell
1,410
-784
-36% -$4.55K ﹤0.01% 3969
2024
Q3
$12.2K Buy
2,194
+293
+15% +$1.96K ﹤0.01% 3608
2024
Q2
$14.2K Buy
1,901
+711
+60% +$4.39K ﹤0.01% 3959
2024
Q1
$6.9K Sell
1,190
-2,711
-69% -$13.6K ﹤0.01% 4299
2023
Q4
$19.3K Sell
3,901
-1,723
-31% -$8.88K ﹤0.01% 3673
2023
Q3
$28.8K Buy
5,624
+5,256
+1,428% +$31K ﹤0.01% 3057
2023
Q2
$2.49K Buy
368
+261
+244% +$1.55K ﹤0.01% 5194
2023
Q1
$1K Buy
+107
New +$479 ﹤0.01% 5505
2022
Q2
Sell
-1,822
Closed -$18K 6089
2022
Q1
$18K Buy
1,822
+1,214
+200% +$11.9K ﹤0.01% 3615
2021
Q4
$6K Buy
608
+68
+13% +$664 ﹤0.01% 5010
2021
Q3
$5K Buy
540
+384
+246% +$3.72K ﹤0.01% 4831
2021
Q2
$2K Buy
+156
New +$1.53K ﹤0.01% 5022

Other funds holding BTMD

Tower Research Capital (TRC)'s BTMD Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Biote Corp (BTMD) stake by 233% in Q1 2026, buying an estimated $18.8K and bringing the position to 13,361 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #3549.

Tower Research Capital (TRC) first reported a position in BTMD in Q2 2021 and has held it in 17 quarters since. The position peaked at $57.5K in Q1 2025. 84 funds tracked by Wall St. Rank hold BTMD as of Q1 2026.

  • Tower Research Capital (TRC) held 13,361 shares of Biote Corp worth $18K as of Q1 2026.
  • Tower Research Capital (TRC) bought 9,349 Biote Corp shares in Q1 2026, an estimated $18.8K.
  • Biote Corp made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3549 holding.
  • Tower Research Capital (TRC) first reported a position in Biote Corp in Q2 2021 and has held it in 17 quarters since.
  • Tower Research Capital (TRC)'s Biote Corp position peaked at $57.5K in Q1 2025.
  • 84 funds tracked by Wall St. Rank held Biote Corp as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.